Vanderbilt Center for Antibody Therapeutics (VCAT) Archive — Page 1 of 13

September 30, 2026

Silent Sentinels sculpture celebrates the invisible power of Vanderbilt Health’s antibody research

By translating the invisible architecture of immunity into a compelling visual experience, the work celebrates the dedication of those working at the forefront of antibody research.

By Bill Snyder
September 28, 2026

California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing

The human monoclonal antibodies were isolated from two individuals who had been infected by measles. Further development and clinical testing could lead to the first monoclonal antibody therapy against the highly infectious respiratory virus.

By Bill Snyder
(iStock)
May 28, 2026

Vanderbilt Health researchers call for pandemic prevention

The Vanderbilt Center for Antibody Therapeutics has received large-scale government grants and contracts to fund the discovery of human antiviral antibodies. The problem is the next step — finding corporate partners to develop the antibodies through human testing.

By Bill Snyder
April 3, 2026

Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment

“These antibodies hold significant promise to be used in people who are at risk of measles, but who cannot respond to the measles vaccine due to their weakened immune systems,” said James Crowe Jr., MD, whose research team isolated the human monoclonal antibodies.

By Bill Snyder
February 20, 2026

Ancient teeth, enduring patterns: Mummy study supports oral-cardiovascular disease link

CT scans of 37 Egyptian mummies found strong correlations between oral disease and calcified blood vessels, offering new evidence that the link between dental and cardiovascular health spans 4,000 years of human history.

By Bill Snyder
(iStock)
February 13, 2026

Anti-Marburg antibody from Vanderbilt Health sent to Ethiopia during outbreak

There currently are no approved treatments or vaccines to protect against the infection, which can cause internal bleeding, organ failure, and in roughly 50% of cases, death.

By Bill Snyder